MED vs USNA

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 10, 2026

MED

47.5
AI Score
VS
MED Wins

USNA

32.4
AI Score

Investment Advisor Scores

MED

48score
Recommendation
HOLD

USNA

32score
Recommendation
SELL

AI Analyst Insights

Detailed Metrics Comparison

Metric MED USNA Winner
Forward P/E 12.4844 8.4531 USNA
PEG Ratio 0.972 0.7043 USNA
Revenue Growth -27.6% -5.3% USNA
Earnings Growth -87.2% -16.6% USNA
Tradestie Score 47.5/100 32.4/100 MED
Profit Margin -8.1% -2.4% USNA
Beta 1.00 1.00 Tie
AI Recommendation HOLD SELL MED

Relative Price Performance (Last 90 Days)

MED 1M: +3.9% · 3M: +1.0% USNA 1M: +10.9% · 3M: -24.4%

Current Technical Phase

MED

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (2.4% over 20 days), RSI 53

RSI (14): 52.8 · Price: $12.04

USNA

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 47

RSI (14): 47.0 · Price: $15.02

Fundamentals Snapshot

Metric MED USNA
Market Cap
Forward P/E -43.0 8.5
Trailing P/E
Revenue (TTM)
Revenue Growth -0.3% -0.1%
Gross Margin 0.7% 0.8%
Operating Margin -0.1% 0.0%
EPS -2.31 -1.16
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, MED is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.